Are Research Peptides Legal in the UK?

For in-vitro laboratory research use only. Not for human or veterinary use. Corex Vitality™ supplies research compounds to adults (18+) for laboratory research. Nothing on this page is medical or legal advice.

Short answer: there is no single yes or no. Whether a peptide product is treated as a controlled drug, a medicine or a research chemical depends on what the compound is, how it is presented and what it is said to do. This page explains the main UK rules in plain English. If you need advice for your own situation, speak to a qualified solicitor.

1. Controlled drugs (Misuse of Drugs Act 1971)

The Misuse of Drugs Act 1971 lists controlled drugs in Schedule 2. BPC-157, TB-500 and GHK-Cu are not listed there, so they are not controlled drugs under the Act.

Not being a controlled drug does not mean a product can be sold for any purpose. The medicines rules below still apply.

Source: Misuse of Drugs Act 1971, Schedule 2

2. When does a product count as a medicine? (the MHRA test)

Under regulation 2 of the Human Medicines Regulations 2012, a product is a medicinal product if either of these applies:

• By presentation: it is presented as treating or preventing disease in people.
• By function: it can be used in, or given to, people to restore, correct or modify a bodily function, or to make a medical diagnosis.

The MHRA explains how it applies this test in Guidance Note 8 (GN8). The MHRA judges each product case by case, on its presentation and its function. It looks at the whole picture, including:

• product names, labels and packaging
• website text, linked articles and publications
• testimonials and social media posts
• the product form (GN8 gives capsules, tablets and injections as examples) and the way it is to be used

The MHRA has said it disregards claims that products are for “research purposes” if it is clear that such claims are being used as an attempt to avoid medicines regulations.

A product that counts as a medicine needs a marketing authorisation, and selling or supplying it without one is an offence.

Sources: Human Medicines Regulations 2012, regulation 2 · MHRA Guidance Note 8: A guide to what is a medicinal product · MHRA statement quoted in The Pharmacist

How Corex Vitality™ presents its products

• Every product is labelled and listed for in-vitro laboratory research only. Not for human or veterinary use.
• We give no health, clinical or cosmetic claims and no instructions for human or animal use.
• We cite published studies only as scientific background, and only studies that describe laboratory or chemistry research.
• We sell only to adults aged 18 or over.

3. Recent UK enforcement (context)

UK authorities have acted against people making and selling peptides and GLP-1-type compounds for human use.

• In October 2025, the MHRA dismantled an illegal manufacturing site for unlicensed GLP-1-type medicines in Northampton.
• In February 2026, MHRA officers raided two premises, including a farm near Sleaford in Lincolnshire, and seized unlicensed medicines awaiting dispatch, including retatrutide and tirzepatide, as well as peptide products.
• In April 2026, the MHRA said it was investigating UK clinics that were making medicinal claims for peptides.

These cases show the MHRA judges how a product is actually sold and used, not just what the label says.

Sources: MHRA press release, 25 February 2026 · The Guardian, 4 April 2026

4. Sport and anti-doping

The World Anti-Doping Agency (WADA) Prohibited List applies to athletes who are subject to anti-doping rules. On the 2026 list:

• BPC-157 is named under S0 (non-approved substances).
• TB-500 is named under S2 (peptide hormones, growth factors, related substances and mimetics).

Both sections are prohibited at all times, in and out of competition.

Source: WADA Prohibited List

5. Other rules that may apply

• Psychoactive Substances Act 2016. It is an offence to supply a psychoactive substance if the supplier knows, or is reckless as to whether, it is likely to be consumed for its psychoactive effects. Corex Vitality™ supplies research compounds for in-vitro laboratory work only.
• Cosmetics. If a product such as GHK-Cu were promoted as a cosmetic, the UK cosmetics rules would apply. We do not sell it as a cosmetic.
• Advertising (ASA/CAP Code). Ads must not make medicinal claims for products that are not authorised medicines. This covers websites and social media as well as paid ads.
• Prices (Digital Markets, Competition and Consumers Act 2024). Prices on a website must be accurate and shown in full. The same Act covers misleading price comparisons and bans fake reviews.

Source: Psychoactive Substances Act 2016

FAQ

Research the range

• Research peptides UK: range, prices and COAs
• How to verify a peptide COA
• Trusted peptide companies UK: what to check
• About Corex Vitality™

References

All references were checked against PubMed using NCBI E-utilities on 2 Nov 2026. They are listed for background only. They are not claims about any Corex Vitality™ product.

1. Ashraf AR, Mackey TK, Vida RG, et al. Multifactor quality and safety analysis of semaglutide products sold by online sellers without a prescription: market surveillance, content analysis, and product purchase evaluation study. J Med Internet Res. 2024;26:e65440. doi:10.2196/65440. PMID 39509151
2. Willis J, Vu N. Synthetic peptides in pharmacy compounding: analysis of PCAC recommendations and industry safety standards. Int J Pharm Compd. 2026;30(4):329-336. PMID 42752426
3. Cox HD, Miller GD, Eichner D. Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H. Drug Test Anal. 2017;9(10):1490-1498. doi:10.1002/dta.2152. PMID 28035768
4. D’Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. doi:10.1016/j.jpba.2014.06.012. PMID 25044089